The expression of Forssman-type heterophile antigen on Marek's disease (MD) virus (MDV)-transformed cell lines, MDCC-MSB 1, -HP 1, -RP 1 and -BP 1, and avian leukosis virus (ALV)-transformed cell lines, LSCC-1104B1 and -1104X5 was investigated by membrane immunofluorescence and complement-dependent antibody cytotoxicity tests. Forssman antigen was detected on a high percentage of the cells in two ALV-transformed cell lines and on a smaller percentage of splenic lymphocytes from normal chicken. Of the MDV-transformed cell lines tested only the RP1 and BP1 cell lines, derived from transplantable MD tumours, expressed Forssman antigen, while the MSB 1 and HP 1 cell lines, derived from MD lymphomas, did not. Forssman antigen appears to be unrelated to MD tumour-associated surface antigen (MATSA).
The changes in surface antigens accompanying transformation of cells by viruses are of particular interest because of their possible role in tumour immunity. Forssman-type heterophile antigen is newly induced in the course of transformation of baby hamster kidney (BHK) cells by SV40 (Robertson & Black, 1969) , and polyoma or Rous sarcoma virus (Fogel & Sachs, 1964; O'Neill, 1968) . Forssman activity was also detected in the plasma membrane of non-transformed BHK cells after brief treatment with protease (Burger, 1971 ).
Marek's disease (MD) is an extensively studied lymphoproliferative disease of chickens caused by a herpesvirus of MD virus (MDV). Since an MD lymphoma-derived lymphoblastoid cell line was first established by Akiyama et al. (1973) , a number of cell lines have been established. AU of these cultured cells have been shown to carry both a T-ceU marker (Nazerian & Sharma, 1975; Matsuda et al., 1976a; Calnek et al., 1978) and MD tumour-associated surface antigen (MATSA) (Powell et al., 1974; Witter et al., 1975; Matsuda et al., 1976b) . On the other hand, cell lines derived from lymphomas of lymphoid leukosis (LL) caused by avian leukosis virus (ALV) have been shown to carry a B-cell marker (Matsuda et al., 1976a) and have been used as a negative control of MATSA. However, the exact nature of MATSA is not clearly understood. Dissimilarity or partial qualitative differences of MATSA in different MD cell lines have been noted (Witter et al., 1975; Sharma et al., 1977; Nazerian et al., 1977; Sugimoto et al., 1979; Rennie & Powell, 1979) . Recently we demonstrated the presence of Hanganutziu and Deicher (H-D)-like heterophile antibody in chicken anti-MATSA sera (Ikuta et aL, 1980) . Therefore, we suggested that the so-called MATSA proposed by Witter et al. (1975) consists of at least two types of antigen, H-D-like heterophile antigen and another antigen. In this paper, the expression of Forssman antigen on MDV and ALV-transformed cell lines was studied to examine the relationship between Forssman antigen and MATSA.
The MDV-transformed cell lines used were MDCC-MSB 1 (Akiyama & Kato, 1974) and MDCC-HP1 (Powell et al., 1974) , which were derived from MD lymphomas, and MDCC-RP1 (Nazerian et al., 1977) and MDCC-BP1 (Sekiya et al., 1977) , which were derived from the transplantable MD tumour, JMV (Sevoian et al., 1964) . The ALV- 1-4)Glc-ceramide] used were described previously (Naiki, 1971; Naiki et aL, 1972) .
Anti-Forssman serum was obtained from rabbits immunized with Forssman glycolipid mixed with an equal amount of methylated bovine serum albumin as described previously (Kato et aL, 1978) . Rabbit anti-sheep erythrocyte stromata (anti-SES) serum purchased from Microbiological Associates (Bethesda, Md., U.S.A.) was also used as an anti-Forssman serum after absorption with bovine red blood cells (BRBC). The heterophile antibody titre was assayed by agglutination of sheep red blood cells (SRBC) or haemolysis of BRBC on a microplate in the presence of 1% foetal calf serum to exclude a non-specific reaction, according to the method of Payne & Norrby (1976) . Serial dilutions of antiserum (25 ~zl) and 0.5% SRBC or BRBC (25 #1) were mixed. Guinea-pig complement was used for the haemolysis. Titres are shown as the reciprocal of the highest dilution showing complete agglutination and haemolysis. Inhibition of SRBC agglutination was tested by addition of 25 #1 Forssman glycolipid (10, 100 or 500 /tg/ml in PBS containing 0.05% sodium taurodeoxycholic acid) as described by N aiki & Marcus (1974) . Three kinds of heterophile antigen or antibody, Forssman (Forssman, 1911) , H-D (Hanganutziu, 1924; Deicher, 1926) and Paul-Bunnell (P-B; Paul & Bunnell, 1932) , have been described. Forssman antibody was distinguished from the other two heterophile antibodies by the differential absorption test of Davidsohn (1938) , showing that it is absorbable with SRBC or guinea-pig kidney ceils (GPKC), but not with BRBC. Table 1 shows the specificities of two types of anti-Forssman serum. An antiserum against Forssman glycolipid agglutinated SRBC up to 512-fold dilution, but did not haemolyse BRBC, and its agglutinating antibody was removed by absorption with GPKC, but not with BRBC. The SRBC agglutination of this anti-Forssman serum was clearly inhibited by the addition of purified Forssman glycolipid. The specificity of Forssman antibodies in anti-SES serum was examined similarly. Non-absorbed anti-SES serum agglutinated SRBC up to a 1024-fold dilution, and also haemolysed BRBC up to a 32-fold dilution. Absorption with 148
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GPKC reduced the SRBC agglutinin titre from 1024 to 64, but did not change the BRBC haemolysin titre. On the other hand, absorption with BRBC did not remove most of the SRBC agglutinin, although it completely removed BRBC haemolysin. These results indicate that this anti-SES serum contained Forssman and probably P-B types of antibodies, and that the latter antibodies were removed by absorption with BRBC. However, even after the absorption, some SRBC-agglutinating antibody activity was detected in the presence of purified Forssman glycolipid, suggesting that this anti-SES serum contained other unknown types of SRBC-agglutinating antibodies as well as Forssman and P-B antibodies. These two types of antisera against Forssman antigen were used to demonstrate Forssman antigen on avian lymphoblastoid line cells, by indirect membrane immunofluorescence (MIF) or complement-dependent antibody cytotoxicity (CDAC) tests ( Table 2 ). The indirect MIF test was performed by the method of Witter et al. (1975) with slight modifications. Briefly, about 2 x 106 cells were suspended in 25 gl of serial fourfold dilutions of anti-Forssman serum, and then incubated for 30 min at 37 °C. Then the ceils were washed twice with a large volume of PBS, suspended in 25/21 fluorescein-conjugated goat anti-rabbit IgG and incubated for 30 min at 37 °C. The cells were again washed twice with a large volume of PBS, and then a drop of cell suspension was placed on a coverslip and promptly examined with a fluorescence microscope. The CDAC test was carried out as follows: 25 gl live cells (5 × 106 cells/ml) were mixed with 25 #1 of serial fourfold dilutions of anti-Forssman serum and 25 gl of tenfold diluted guinea-pig complement, and incubated for 1 h at 37 °C. The number of living cells after incubation was counted by trypan blue dye exclusion. As a control, fourfold diluted normal rabbit serum was used in place of anti-Forssman serum. The cytotoxic index (CI) was calculated by the following formula:
Number of viable cells in control -Number of viable cells in test sample CI (%) = x 100 Number of viable cells in control
The indirect MIF test with antiserum against Forssman glycolipid showed the expression of Forssman antigen with a high percentage (more than 90%) on the cell surface of the 1104B 1 cell line derived from LL lymphoma, and on the RP1 and BP1 lines derived from transplantable MD tumours. About 60% of the cells in the 1104X5 cell line derived from an LL lymphoma also had Forssman antigen. A smaller percentage (about 20%) in the splenic lymphocytes from a normal 6 month-old chicken also expressed Forssman antigen. Spleen lymphocytes from normal chickens of different ages showed similar extents of expression of the antigen. The fluorescence was seen on most cells as a ring, but on a few it was seen as patches. On the other hand, no antigen was detectable on two cell lines derived from MD lymphomas (MSB 1 and HP 1) with this anti-Forssman serum. Similar results were obtained by the CDAC test with antiserum against Forssman glycolipid or anti-SES serum absorbed with BRBC.
The positive reactions in MIF and CDAC tests were specifically inhibited by addition of 25 gl Forssman glycolipid (500 gg/ml). These results suggest that ALV-transformed lymphoblastoid cells and transplantable MD tumour-derived cells express Forssman antigen on their surface, but that the antigen is not expressed on the surface of MD lymphoma-derived cells, such as MSB 1 and HP 1. The number of Forssman-positive cells of 1104X5 was smaller than that of 1104B 1. Although these two LL lymphoma-derived cell lines were established from the same origin, a tumour lesion of the bursa of Fabricius in a chicken (Hihara et al., 1974) , the 1104X5 cell line is spindle-shaped and loosely attached to the glass forming a cell sheet, whereas 1104B 1 is a floating cell line.
A certain proportion of the splenic lymphocytes obtained from a 6 month-old chicken was found to express Forssman antigen. The splenic lymphocytes were fractionated into T-lymphocytes and B-lymphocytes by a nylon wool column according to the method of et al. (1978) . Indirect MIF tests using anti-T-and anti-B-lymphocyte-specific sera on the fractionated T-cells and B-cells showed that the fractions were both about 90% pure. Expression of Forssman antigen on these fractionated lymphocytes was examined by the indirect MIF test with antiserum against Forssman glycolipid (Table 2) . About 40% of the B-lymphocyte fraction were found to express Forssman antigen. A small percentage of the T-lymphocyte fraction also gave a positive reaction for this antigen, although it is not known whether this positive reaction is due to the low level of B-cell contaminants in the T-cell fraction. Among MD cell lines examined, Forssman antigen was detected only on transplantable MD tumour, JMV-derived cell lines. The JMV tumour was originally developed by a rapid and blind passage of MD lymphoma cells (induced by the JM strain of MDV) in chickens (Sevoian et al., 1964) . This highly malignant tumour kills chicks in 5 to 8 days, much less time than is required for induction of tumours by inoculation of the virus or virus-producer cell lines such as MSB 1. The RP 1 and BP 1 cell lines are derived from this JMV tumour, and have a T-ceU marker and MATSA, but lack any MDV rescuable in vivo or in vitro (Nazerian et al., 1977; Sekiya et al., 1977) . On the other hand, the MSB1 and HP1 line cells, which are derived from MD lymphomas, also have a T-cell marker and MATSA, but produce MDV. The characteristics of naturally occurring MD lymphomas resemble those of MSB 1 and HP 1, but differ from those of RP1 and BP1. In addition, a qualitative difference of MATSA in different MD cell lines has been reported (Witter et al., 1975; Sharma et al., 1977; Nazerian et al., 1977; Sugimoto et al., 1979; Rennie & Powell, 1979) . Results have shown a similarity of the MATSA in MSB 1 and HP 1, and also in MD lymphoma cells, but a dissimilarity of the MATSA in JMV and MSB1, or HP1. Our preliminary examination on the expression of Forssman antigen in liver lesion showed that LL lymphoma cells so far examined were positive, while MD lymphoma cells so far examined were almost negative, although liver hepatic cells of normal chickens were completely negative. These results also show a similarity of in vivo MD lymphoma cells to the MSB1 or HP1 cell line, but not to the RP1 or BP1 cell line in terms of Forssman antigenic expression. As far as we examined, Forssman antigen is absent on in vivo MD lymphoma cells and MD lymphoma-derived cell fines, while present on in vivo LL lymphoma cells, LL lymphoma-derived cell lines and transplantable MD tumour-derived cell lines. However, generalization of the association of the expression of Forssman antigen with the origin of lymphoma cells should await further experiments on more cell fines and in vivo lymphomas.
To examine further the relationship of Forssman antigen to MATSA, we prepared anti-MATSA sera from chickens and rabbits by immunizations with the MSB i and BP 1 line cells, as described previously (Matsuda et al., 1976b) . SRBC-agglutinating activity was found in chicken anti-MSB1 and anti-BP1 sera and rabbit anti-BP1 serum, but not in rabbit anti-MSB 1 serum. The agglutinating activities in chicken anti-MSB 1 and anti-BP 1 sera were removed by absorption with BRBC or GPKC, showing that these agglutinating antibodies were H-D-type heterophile antibodies. Rabbit anti-BP1 serum caused agglutination up to 32-fold dilution on the microplate assay described above, and this agglutinating activity was removed by absorption with GPKC, but not with BRBC, showing that the agglutinating antibody was Forssman antibody. However, the SRBC-agglutinating activity of rabbit anti-BP1 serum was removed by extensive absorption with normal chicken blood cells and splenic lymphocytes as done in preparation of anti-MATSA antibody from rabbit antiserum against MD line cells. These results suggest that Forssman antigen is unrelated to MATSA.
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